Communication
a lipid-lowering drug,[16] was successfully aminated in 68%
yield (3pa). Further exploration revealed that a bulkier sub-
strate was also tolerated (3qa). Finally, cyclic substrates also
delivered the products, though in lower yields (3ra–3sa). Intri-
guingly, we found that substrates containing a-hydrogen or
amination of the secondary C(sp3)ÀH bond were not working.
Afterwards, we explored the scope of amine partners. Diverse
alkyl- or aryl-substituted piperidines proceeded the aminations
in good yield (3ab–3ag). Moreover, various functional piperi-
dines with ester, ketal, or ether groups (3ah–3aj) were also
well tolerated. In addition, thiomorpholine and piperazine
were successful as amine partners (3ak, 3al). The scope of
amine can be further expanded to azepane, pyrrolidine, and
azetidine (3am, 3an, 3ao). It is worth noting that diallylamine
also proceeded the amination though in low yield (3ap). The
allyl protection of the product could be removed to release
the amine group, which is a useful handle for further derivati-
zation. However, in general, acyclic dialkylamines or primary al-
kylamines (e.g. Bu2NH, BuNH2) did not currently work as amine
partners. It should be noted that the major mass balance of
those reactions with low yields was the unreacted 1. Overall,
the reaction showed useful substrate scope of quaternary car-
boxylic amides and cyclic alkylamines. The resulting products
are important structural motifs that widely exist in medicinally
and biologically active compounds. The utility of this method
was further highlighted in a synthesis of CNS disorder modula-
tor HY-2901 (Scheme 2).[17] Under the reaction conditions, ami-
nation of 1.0 mmol 1a by 2q successfully afforded 3aq in
62% yield. Removal of the AQ was achieved by NaOEt to
afford HY-2901 in 90% yield.
Table 1. Optimization of the reaction conditions.[a]
Entry
Cu metal (equiv)
Additive
Solvent
Yield [%][b]
1
2
3
4
5
6
7
8
CuI (0.2)
CuBr2 (0.2)
CuF2 (0.2)
DMSO
DMSO
DMSO
DMSO
DMSO
DMF
trace
0
5
0
18
11
Cu(TFA)2 (0.2)
Cu(OAc)2 (0.2)
Cu(OAc)2 (0.2)
Cu(OAc)2 (0.2)
Cu(OAc)2 (0.2)
Cu(OAc)2 (0.2)
Cu(OAc)2 (0.2)
Cu(OAc)2 (0.2)
Cu(OAc)2 (1.0)
Cu(OAc)2 (1.0)
Cu(OAc)2 (2.0)
Cu(OAc)2 (3.0)
Cu(OAc)2 (2.0)
Cu(OAc)2 (2.0)
toluene
DCE
0
0
9
CH3CN
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
DMSO
trace
9
trace
47
15
72
71
trace
trace
10[c]
11[d]
12
13[e]
14[f]
15
16[g]
17[h]
Ag2CO3, NMO
IBD
Na2CO3
[a] General procedure: 1a (0.20 mmol), 2a (0.60 mmol), Cu metal
(x equiv), and additive (x equiv) in solvent (2.0 mL) under O2 at 1308C for
2 h. [b] Determined by 1H NMR analysis of the crude product using
CH2Br2 as the internal standard. [c] Ag2CO3 (0.2 equiv), NMO (2 equiv). 1a
recovered in 90%. [d] IBD (PhI(OAc)2) (2 equiv). [e] Na2CO3 (2 equiv). 1a
recovered in 60%. [f] 1a recovered in 13%. [g] Reaction under Ar. [h] Re-
action at 1108C.
72% when two equivalents of Cu(OAc)2 were used (entry 14).
A further increase in the amount of Cu(OAc)2 to three equiva-
lents had no positive effect on the yield (entry 15). Dioxygen
was essential to the reaction (entry 16). Lowering the reaction
temperature to 1108C led to no reaction (entry 17). Overall, the
optimal reaction conditions were using two equivalents
Cu(OAc)2 in DMSO under O2 at 1308C.
Next, we evaluated the potential of other known directing
groups in assisting this transformation, including the perfluor-
oaniline,[15a] 2-(pyridine-2-yl)-isopropylamine,[15b] 2-methylthioa-
niline,[15c] picolinamide,[15d] 2-aminopyridine N-oxide,[15e] and 2-
(4,4-dimethyl-4,5-dihydrooxazol-2-yl)aniline.[15f] We found that
none of those groups were effective in directing the amination
under the reaction conditions (see the Supporting Informa-
tion).
Scheme 2. Synthesis of CNS disorder modulator HY-2901.
With the optimal conditions in hand, we explored the reac-
tion scope (Table 2). Substrates with simple aliphatic chains
were well tolerated to deliver the products in good yields
(3ba–3 fa). Sterically hindered aryl analogues afforded the
product in moderate yield (3ga). Benzyl analogues regardless
of their electronic properties were well tolerated to give the
products (3ha–3ma). The aryl substitution of the substrate
can be further extended to the d-position to proceed the ami-
nation (3na). An olefinic substrate was also tolerated (3oa).
Late-stage functionalization of pharmaceutical agents could di-
versify the chemical structure with the potential to modify the
PK/PD profiles of the agent. An analogue of gemfibrozil,
The preliminary data of kinetic isotope experiments (parallel
intermolecular KIE=2.7, see the Supporting Information) im-
plied that the cleavage of the b-C(sp3)ÀH bond occurred as the
rate-limiting step. It was found that radical quencher 2,2,6,6-
tetramethylpiperidine N-oxide (TEMPO) inhibited the reaction
between 1a and 2a completely, suggesting a radical pathway
was involved. Additionally, we found that in the absence of
2a, 1a produced acetoxylation and hydroxylation product 5
and 6 in 8 and 21% yield, respectively, under the conditions.
Based on these observations, we putatively proposed a reaction
pathway (Scheme 3). First, complexation of 1a with Cu(OAc)2
generated intermediate I. Then a base-assisted C(sp3)ÀH activa-
&
&
Chem. Eur. J. 2016, 22, 1 – 6
2
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!